fluorodeoxyglucose f18 has been researched along with Lung Diseases in 140 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.71) | 18.7374 |
1990's | 14 (10.00) | 18.2507 |
2000's | 54 (38.57) | 29.6817 |
2010's | 58 (41.43) | 24.3611 |
2020's | 13 (9.29) | 2.80 |
Authors | Studies |
---|---|
Lu, T; Yang, G | 1 |
Fujito, T; Ikeda, T; Ishida, J; Kondo, Y; Kuno, Y; Miyazaki, S; Mori, S; Nara, Y; Yamashita, R | 1 |
Arii, K; Matumoto, M; Okamoto, T; Shinohara, T; Sumitomo, K | 1 |
Ahad Aziz Qureshi, PA; Hassan, A; Niazi, IK | 1 |
Arora, S; Chakraborty, D; Kumar, R; Prabhu, M; Raju, S | 1 |
Aladjidi, N; Amoura, Z; Boussouar, S; Charlotte, F; Cohen Aubart, F; Donadieu, J; Emile, JF; Grenier, P; Haroche, J; Maksud, P; Moyon, Q; Prévot, G | 1 |
Alavi, A; Dreyfuss, AD; Jahangiri, P; Simone, CB | 1 |
Casali, M; Cecchin, D; Evangelista, L; Fraia, AS; Giraudo, C; Lupi, A; Quaia, E | 1 |
Cheng, D; Hu, B; Shi, H; Xiao, J; Xiu, Y | 1 |
Ballout, S; Chen, DL; Chen, L; Cheriyan, J; Choudhury, G; Denis-Bacelar, AM; Emond, E; Erlandsson, K; Fisk, M; Fraioli, F; Groves, AM; Gunn, RN; Hatazawa, J; Holman, BF; Hutton, BF; Iida, H; Lee, S; MacNee, W; Matsunaga, K; Mohan, D; Parr, D; Rashidnasab, A; Rizzo, G; Subramanian, D; Tal-Singer, R; Thielemans, K; Tregay, N; van Beek, EJR; Vass, L; Vidal Melo, MF; Wellen, JW; Wilkinson, I; Wilson, FJ; Winkler, T | 1 |
Abe, S; Ikeda, N; Maehara, S; Ohira, T; Shimada, Y; Yamada, T; Yamamichi, T; Yoshimura, A | 1 |
Chen, J; Qi, L; Xu, C; Zhang, L; Zhang, X; Zhang, Y | 1 |
Consul, N; Namireddy, MK; Sher, AC | 1 |
Huang, Z; Liu, Y; Tao, Y; Wang, F | 1 |
Basu, S; Joshi, JM; Karkhanis, VS; Yadav, M | 1 |
Abayaweera, G; Abou-Taleb, HA; AbouElhassan, KM; AbouTaleb, HA; Adair, LS; Adams, E; Addison, O; Addy, I; Akhtar, N; Alten, B; Anesini, J; Añez, R; Angaridis, PA; Aouba, A; Arakawa, K; Aumeeruddy-Elalfi, Z; Bao, LP; Basu, E; Bayraktar, E; Bekkelund, CS; Bell, J; Beraldo, H; Bermúdez, V; Betenbaugh, MJ; Bhattacharya, R; Bienvenu, B; Bolzoni, M; Bootz, F; Borja, JB; Bove, DG; Bowden, ME; Bradsher, C; Brockstedt, D; Brothers, RM; Buschauer, A; Calandriello, L; Caporossi, A; Carba, DB; Carratalà, J; Castella, B; Caviezel, D; Ceccato, R; Charalambidis, G; Charisiadis, A; Chattopadhyay, P; Chen, Q; Chen, W; Chen, Y; Chen, YT; Chen, ZJ; Chen, ZY; Cheng, MA; Cheng, ZB; Cherevko, S; Cheung, IY; Cheung, NV; Chiappini, A; Chiu, YL; Choi, IG; Chough, S; Chung, CY; Cobb, A; Colotto, A; Continentino, MA; Cook, AJMC; Costa, F; Coutsolelos, AG; Cuperus, N; Curtis, BM; Davenport, AJ; de Boysson, H; Dela, F; Deng, XP; Deshayes, S; Dhara, K; Dietrich, D; Dietrich, J; Dilhari, A; Ding, R; Ding, Y; Dirè, S; Dohlmann, TL; Dotsenko, A; Doubrovina, E; Du, K; Du, ZJ; Duvic, M; Eastman, A; Eliakim-Raz, N; Elz, S; Emile, JF; Emmerling, C; Engelhard, MH; Eriksson, JG; Etzold, BJM; Faini, AC; Falsini, B; Farmer, E; Fei, JJ; Ferreira, IP; Föttinger, K; Franconieri, F; Fryda, NJ; Fuentes, I; Galateau-Sallé, F; Ganguly, M; Gani, BA; Gao, X; Gao, XF; Gao, XJ; García-Mendiola, T; Garg, A; Gascon, J; Gayani, B; Gevensleben, H; Gilbert, M; Giudiceandrea, A; Giuliani, N; Gocmen, AY; Goldman, DA; Goltz, D; Gombert, AK; Gomila, A; Goodwin, P; Górnicki, K; Gostin, PF; Graterol, M; Gremillet, C; Grier, S; Grün, AL; Gusakov, A; Halldórsdóttir, HR; Han, L; Han, Z; Hävecker, M; Helge, JW; Heo, K; Hernández, JD; Hindsø, M; Holmen Olofsson, G; Hong, CE; Hong, J; Horenstein, AL; Hosenally, M; Hruz, P; Hsu, HL; Hsu, KC; Hu, SF; Hu, Y; Huang, K; Huang, S; Huang, WH; Humaira, A; Hung, CF; Hung, WS; Huo, XK; Huvinen, E; Idorn, M; Ignatyev, K; Im, WT; Ismaël, IS; Jakobsson, JG; Janaszek-Mańkowska, M; Jeong, GT; Ji, L; Ji, X; Jiang, Y; Jo, IH; Jo, SH; Johnson, AC; Johnson, LE; Kadirvelu, K; Kahnt, A; Kaleta, A; Kamiya, T; Kang, DH; Kang, XH; Kashiwagi, T; Katayama, E; Kawachi, N; Keller, M; Kellermann, L; Khan, T; Khan, ZA; Kharshoum, RM; Khim, JS; Kikuchi, M; Kim, BS; Kim, DS; Kim, DW; Kim, JH; Kim, JJ; Kim, JU; Kim, SK; Kim, WS; Kimura, J; Kiss, C; Knop-Gericke, A; Kobayashi, S; Koivusalo, SB; Kolar, E; Kottegoda, N; Kramer, K; Kristiansen, G; Kruger, AA; Kumar, S; Kumar, V; Kumarage, S; Kursungoz, C; Kushner, BH; Kuwahara, F; Kuzawa, C; Kwon, BO; Landsberg, J; Larsen, S; Lauer, P; Le Luduec, JB; Lee, DW; Lee, H; Lee, HY; Lee, JW; Lee, MJ; Lee, SW; Lefrançois, P; Leibovici, L; Leong, KK; Leong, M; Li, B; Li, D; Li, G; Li, J; Li, YZ; Liang, JH; Liang, X; Liens, A; Ligorio, G; Lin, JD; Lindholm, MG; Liou, MJ; List-Kratochvil, EJW; Litvinov, IV; Liu, F; Liu, S; Liu, Y; Liu, Z; Lohar, S; Lopes, MTP; Lorenzo, E; Lu, X; Lukashuk, L; Lukens, WL; Luo, HR; Luo, L; Luttik, MAH; Ma, Y; MacGowan, A; Mahomoodally, MF; Maissen, S; Malavasi, F; Malhotra, M; Mallik, S; Manna, D; Mans, R; Marangoni, D; Marimpietri, D; Marques, F; Marques, WL; Marsaa, K; Martin Silva, N; Martinez, A; Martínez, MS; Massaia, M; Mayrhofer, KJJ; McDade, T; McNeel, DG; Met, Ö; Micalizio, GC; Modak, S; Morandi, F; Moreau, L; Morla, S; Morrell, AP; Morris, S; Mubarak, Z; Muchlisin, ZA; Munoz, M; Nagao, Y; Nakama, T; Nakamura, H; Nakano, T; Nardi, MV; Nasirian, A; Nelson, MD; Netchiporouk, E; Ni, X; Niess, JH; Nijenhuis, JM; Nikolaou, V; O'Connor, BJ; O'Reilly, RJ; Odobel, F; Ohata, C; Ohyama, B; Olivar, LC; Ordoñez, MG; Ostrovnaya, I; Palmar, J; Panda, S; Pandiyarajan, S; Park, B; Park, H; Park, JH; Park, S; Pasquali, L; Patik, JC; Pearce, CI; Peele, ME; Peng, S; Perera, IC; Petty, JT; Pidko, EA; Pinheiro, CB; Pistoia, V; Pita, M; Planchat, A; Plass, F; Pockes, S; Pradhan, N; Premasudha, P; Pronk, JT; Provost, N; Pujol, M; Qi, P; Qiu, J; Qiu, Z; Quan, J; Quaranta, A; Ra, CH; Rameshan, R; Ranglack, DH; Rausch-Fan, X; Rieger, E; Rivas, JR; Roberts, SS; Rocha, WR; Rodrigues, GLS; Rojas, J; Roy, P; Rozhkova, A; Rufo, S; Rupprechter, G; Saeui, CT; Saha, A; Sakai, M; Salazar, J; Salem, HF; Salgarello, T; Samarakoon, SR; Sandau, C; Sandbeck, DJS; Santos, AF; Santos, VG; Sara, Y; Saslow, SA; Sasseville, D; Sato, S; Sauer, JD; Schlögl, R; Schweiger, MJ; Shashkov, I; Shaw, E; Shen, WQ; Shim, J; Shu, J; Singh, C; Sinha Babu, SP; Sinitsyn, A; Sinitsyna, O; Skadborg, SK; Song, Q; Song, W; Stach-Lempinen, B; Stoddart, M; Stoica, M; Street, SR; Sukwong, P; Sun, CP; Sun, J; Sunwoo, IY; Suresh, S; Szécsényi, Á; Takahashi, T; Takeda, S; Tang, D; Tas, ST; Tebé, C; Teixeira, LR; Teixidor, F; Terrier, B; Teschner, D; Tetzlaff, MT; Theisen, E; Thor Straten, P; Tiitinen, A; Timpel, M; Toccoli, T; Torikai, K; Torres, W; Toscani, D; Trad, S; Tsai, HJ; Tseng, CP; Tucker, WJ; Um, W; Vallejo-Torres, L; van den Broek, M; Van den Heuvel, L; van der Woude, LN; van Maris, AJA; Van Schepdael, A; Vank, C; Verucchi, R; Vigo, JM; Viñas, C; Vogt, TJ; Vuong, C; Wai, H; Wang, B; Wang, D; Wang, H; Wang, JJ; Wang, K; Wang, L; Wang, Q; Wang, YR; Watanabe, S; Watters, AK; Weerasekera, MM; Wei, L; Wheeler, DA; Wiegand, I; Wifling, D; Wijesinghe, GK; Winiczenko, R; Wolker, T; Wu, J; Wu, TC; Wu, YY; Xie, P; Xie, YP; Xu, A; Xu, E; Xu, L; Xu, Z; Yamaguchi, M; Yang, A; Yang, G; Yang, J; Yang, TM; Yang, W; Yang, Y; Yarema, KJ; Yesiltepe, M; Yi, KJ; Yigit, N; Yim, UH; Yin, B; Yu, S; Zengin, G; Zhang, B; Zhang, C; Zhang, GR; Zhang, H; Zhang, J; Zhang, L; Zhang, TY; Zhang, X; Zhang, Y; Zhang, YX; Zhao, H; Zhao, JC; Zhao, Z; Zheng, R; Zhou, W; Zorn Morales, N | 1 |
Aydın, F; Boz, A; Bozkurt, S; Cengiz, A; Dertsiz, L; Erkılıç, M; Güngör, F; Özbilim, G; Sipahi, M | 1 |
Lin, J; Tang, K; Wang, L; Wu, Y; Zheng, X | 1 |
Javadi, MS; Rowe, SP; Solnes, LB; Tulbah, RI | 1 |
Das, JP; Ginsberg, MS; Halpenny, DF; Hayes, SA; Riedl, CC; Xie, L | 1 |
Bogsrud, TV; Johnsrud, K; Knudtsen, IS; Revheim, ME; Skretting, A | 1 |
Fu, LP; Li, YG; Liu, CB; Shao, MZ; Tian, JH; Wang, RM; Xu, BX | 1 |
Hayashi, S; Ishibashi, K; Kitada, M; Matuda, Y; Miyokawa, N; Ohsaki, Y; Oikawa, K | 1 |
Petrun'kin, AM; Tlostanova, MS | 1 |
Bal, CS; Karunanithi, S; Sahoo, MK | 1 |
Dhull, VS; Jain, S; Kumar, R; Mukherjee, A; Pal, L; Parida, GK; Sharma, P | 1 |
Niu, R; Wang, C; Wang, X; Zhang, T | 1 |
Baqir, M; Lowe, V; Ryu, JH; Yi, ES | 1 |
Cruz, J; Ferreira, L; Pacheco, C | 1 |
Beer, AJ; Eiber, M; Fürst, S; Nekolla, SG; Rauscher, I; Rummeny, EJ; Schwaiger, M; Souvatzoglou, M; Ziegler, SI | 1 |
Basu, S; Joshi, J; Yadav, M | 1 |
Bitencourt, AG; Chojniak, R; Godoy, MC; Gross, JL; Guimaraes, MD; Hochhegger, B; Marchiori, E; Odisio, BC; Tyng, CC; Zurstrassen, CE | 1 |
Gerbaudo, VH; Wachsmann, JW | 1 |
Aldrich, MC; Blume, JD; Deppen, SA; Grogan, EL; Kensinger, CD; Massion, PP; McPheeters, ML; Morgan, AM; Putnam, JB; Walker, RC | 1 |
El Fakhri, G; Hoog, C; Laine, AF; Li, Q; Lorsakul, A; Ouyang, J; Petibon, Y; Trott, CM | 1 |
Chondrogiannis, S; Colletti, PM; Grassetto, G; Marzola, MC; Milan, E; Rampin, L; Rubello, D; Zorzi, A | 1 |
Li, D; Liu, S; Ming, M; Shi, B; Wang, ZG; Wu, F; Xue, W | 1 |
Basu, S; Joshi, J; Kumar, NS | 1 |
Alifano, M; Caillat-Vigneron, N; Farid, K; Petras, S; Poullias, X; Regnard, JF; Servois, V | 1 |
Chazan, R; Dabrowska, M; Korczynski, P; Krenke, R; Kunikowska, J; Maskey-Warzechowska, M; Orłowski, T; Zukowska, M | 1 |
Liu, HR; Shi, JH; Sun, XF; Wang, P | 1 |
Anić, B; Barešić, M; Brčić, L; Hećimović, A; Janevski, Z; Sreter, KB | 1 |
Alavi, A; Grupe, P; Houshmand, S; Høilund-Carlsen, PF; Salavati, A; Segtnan, EA | 1 |
Bacchus, L; Chung, JH; Crabtree, TP; Heitkamp, DE; Iannettoni, MD; Johnson, GB; Jokerst, C; McComb, BL; Mohammed, TL; Ravenel, JG; Saleh, AG; Shah, RD; Steiner, RM | 1 |
Barbosa, F; Delso, G; Hüllner, M; Khalighi, M; Sekine, T; Ter Voert, E; Veit-Haibach, P | 1 |
Capitanio, S; Noraini, AR; Nordin, AJ; Rossetti, C | 1 |
Han, Y; Li, DC; Liu, SM; Wang, ZG; Wu, FY; Yang, GJ; Yu, MM | 1 |
Chen, DL; Cheriyan, J; Chilvers, ER; Choudhury, G; Coello, C; Connell, M; Fisk, M; Groves, AM; Gunn, RN; Holman, BF; Hutton, BF; Lee, S; MacNee, W; Mohan, D; Parr, D; Subramanian, D; Tal-Singer, R; Thielemans, K; van Beek, EJ; Vass, L; Wellen, JW; Wilkinson, I; Wilson, FJ | 1 |
Chen, CJ; Cheng, L; Chiu, NT; Chu, CL; Lee, BF; Wu, PS; Yao, WJ | 1 |
Boscolo, E; Bussoli, L; Gelain, F; Lubin, E; Pizzolato, R; Quaia, E; Tona, G | 1 |
Berberoglu, K; Dogan, AS | 1 |
Bellomi, M; Guarize, J; Leo, F; Maisonneuve, P; Masullo, M; Pelosi, G; Preda, L; Rampinelli, C; Scanagatta, P; Solli, P; Spaggiari, L; Veronesi, G | 1 |
Bartolomei, M; Bellomi, M; Carbone, G; De Cicco, C; De Pas, T; Paganelli, G; Pelosi, G; Spaggiari, L; Veronesi, G | 1 |
Ameshima, S; Demura, Y; Fujibayashi, Y; Ishizaki, T; Morikawa, M; Okazawa, H; Tsuchida, T; Uesaka, D; Umeda, Y | 1 |
Jeong, YJ; Kim, IJ; Kim, SJ; Kim, YS; Lee, TH | 1 |
Fan, C; Fan, Q; Li, F; Su, M; Tian, Y; Yang, X; Zhuang, H | 1 |
Escalon, MP; Kalkanis, D; Lossos, IS; Paes, F; Serafini, A; Stefanovic, A | 1 |
Aide, N; Hicks, RJ; Irving, L | 1 |
Bradley, KM; Chowdhury, FU; Gleeson, FV; Sheerin, F | 1 |
Araki, O; Chida, M; Honma, K; Karube, Y; Kobayashi, S; Miyoshi, S | 1 |
Banks, KP; Bradley, YC; Cloran, FJ; Kim, Y; Song, WS | 1 |
Blankenberg, FG | 1 |
Dolovich, MB | 1 |
Kawai, H; Muguruma, M; Ohara, T; Watanabe, K | 1 |
Adachi, Y; Fujioka, S; Haruki, T; Miwa, K; Nakamura, H; Taniguchi, Y | 1 |
Pietrzykowski, J; Wardyn, KA; Zielonka, TM | 1 |
Ahn, BC; Lee, J; Lee, SW; Seo, JH | 1 |
Anar, C; Halilçolar, H; Kargi, A; Sanli, A; Unsal, I; Yildirim, Y; Yilmaz, U | 1 |
Erasmus, JJ; Patz, EF | 1 |
Guan, Y; Lin, X; Tan, H; Zhao, J | 1 |
Burger, I; Bussmann, C; Fengels, I; Huellner, MW; Schläpfer, R; Schwizer, B; Strobel, K | 1 |
Brianzoni, E; Crisci, R; De Vico, A; Di Leonardo, G; Di Tommaso, S; Divisi, D | 1 |
Chen, Y; Guan, Z; Liu, C; Shao, M; Tian, J; Wang, H; Wang, R; Xu, B; Yao, S; Yin, D; Zhang, J | 1 |
Bordenave, L; de Clermont, H; Laffon, E | 1 |
Ding, HJ; Hsieh, TC; Kao, CH; Sun, SS; Wang, CH; Wu, YC; Yeh, JJ; Yen, KY | 1 |
Cui, L; Liang, W; Liu, W; Xu, S | 1 |
Deshayes, E; Grange, JD; Kodjikian, L; Maucort-Boulch, D; Rahmi, A; Seve, P; Varron, L | 1 |
Katahira, K; Mori, T; Namimoto, T; Nomori, H; Ohba, Y; Shiraishi, K | 1 |
Liang, W; Liu, W | 1 |
Andrade, G; Deppen, S; Grogan, EL; Lambright, ES; Massion, PP; Nesbitt, JC; Putnam, JB; Speroff, T; Walker, R | 1 |
Mouroux, J; Padovani, B; Pop, D; Rigo, P; Vénissac, N | 1 |
Grant, FD; Treves, ST | 1 |
Francis, R; Morandeau, L; Segard, T | 1 |
Drent, M; Erckens, RJ; Mostard, RL; Nelemans, PJ; van Kroonenburgh, MJ; Verschakelen, JA; Vöö, S; Wijnen, PA | 1 |
Almuhaideb, A; Bomanji, J; Iordanidou, L; Saad, Z; Syed, R | 1 |
Baslund, B; Graudal, N; Larsen, J; Loft, A; Milman, N; Mortensen, J | 1 |
Berthier, S; Dhote, R; Fain, O; Federici, L; Jaccard, A; Launay, D; Lefèvre, G; Mekinian, A; Soussan, M; Valeyre, D | 1 |
He, J; Ye, Q; Zhi, K | 1 |
Nagao, T; Nakano, Y; Sakashita, T; Shigemori, W; Wada, H | 1 |
Dence, CS; Factor, P; Ferkol, T; Luker, GD; Piwnica-Worms, D; Ponde, DE; Reynolds, PN; Richard, JC; Schuster, DP; Sharma, V; Zhou, Z | 1 |
Alavi, A; Duarte, PS; Feng, Q; Rebenstock, A; Zhuang, H | 1 |
Bandoh, S; Fujita, J; Ishida, T; Ishii, T; Kubo, A; Nishiyama, Y; Tojo, Y; Ueda, Y; Yamamoto, Y | 1 |
Hicks, RJ; Mac Manus, MP | 1 |
Nguyen, M; Perez, R; Schuster, DM; Varma, V | 1 |
Chen, DL; Ferkol, T; Richard, JC; Schuster, DP | 1 |
Aquino, SL; Asad, S; Fischman, AJ; Piyavisetpat, N | 1 |
Carreras, JL; de Juan, R; Lapeña, L; Montz, R; Peñas, JM; Ruiz-Hernández, G; Samanes, A; Verea, H; Veres, A | 1 |
Naruke, T; Nomori, H; Ohtsuka, T; Suemasu, K; Uno, K; Watanabe, K | 1 |
Knight, S; Ollenberger, GP; Tauro, AJ | 1 |
Cerfolio, RJ; Chen, VK; Desmond, R; Eloubeidi, MA; Ojha, B; Syed, S | 1 |
Alavi, A; Cheng, E; Kumar, R; Xiu, Y; Yu, JQ; Zhuang, H | 1 |
Hirabayashi, H; Maeda, J; Matsuda, H; Ohta, M | 1 |
Cohen, M; Grubstein, A; Kramer, MR; Sapir, EE; Shitrit, D | 1 |
Gupta, P; Kramer, EL; Ponzo, F | 1 |
Fisher, RE; Lam, D; Lynch, GR; Mascarenhas, NB | 1 |
Choi, JY; Chung, MJ; Kim, BT; Lee, EJ; Lee, KS; Shim, SS | 1 |
Chung, SK; Chung, YA; Hyun, J; Kin, SH; Park, HJ; Sohn, HS; Yoo, IeR | 1 |
Bryant, AS; Cerfolio, RJ | 1 |
Fukunaga, K; Iwado, Y; Nishiyama, Y; Ohkawa, M; Satoh, K; Takinami, H; Yamamoto, Y | 1 |
Gotoh, M; Igai, H; Yokomise, H | 1 |
Adler, BH; Binkovitz, LA; Nicol, KK; Rennebohm, RM; Young, AS | 1 |
Farukhi, I; Hughes, RS; Oz, OK; Shie, P | 1 |
Allen-Auerbach, M; Brown, M; Czernin, J; Dahlbom, M; Fueger, BJ; Goldin, J; Kim, SK; Schiepers, C | 1 |
Akdemir, UO; Benekli, M; Buyukberber, S; Coskun, U; Kapucu, O; Kaya, AO; Yildiz, R | 1 |
Ameshima, S; Demura, Y; Ishizaki, T; Itoh, H; Mizuno, S; Morikawa, M; Nakanishi, M; Sasaki, M; Takeda, N; Uesaka, D; Umeda, Y | 1 |
Biesma, DH; Grutters, JC; Post, MC; Verzijlbergen, JF | 1 |
Bae, YA; Choe, BK; Chung, MJ; Jeong, SY; Kim, BT; Kim, TS; Lee, KS; Shin, KM | 1 |
Bischoff, HG; Knopp, MV | 1 |
Burrowes, P; Coleman, RE; Goodman, PC; Hoffman, JM; Lowe, VJ; Paine, SS; Patz, EF | 1 |
Delbeke, D; Knight, SB; Sandler, MP; Stewart, JR | 1 |
Anscher, MS; Hebert, ME; Hoffman, JM; Lowe, VJ; Patz, EF | 1 |
Buonocore, E; Dickey, J; Gould, HR; Hübner, KF; Smith, GT; Stephens, S; Thie, J | 1 |
Coleman, RE; Delong, DM; Duhaylongsod, FG; Hoffman, JM; Lowe, VJ; Patz, EF; Wolfe, WG | 1 |
Bakheet, SM; Powe, J | 1 |
Bishop, H; Gill, H; Graeber, G; Gupta, N; Hurst, J; Stephens, T | 1 |
Chang, YL; Chen, ML; Chieng, PU; Ko, SC; Liu, FY; Su, CT; Yen, RF | 1 |
Coleman, RE; Laymon, CM; Turkington, TG | 1 |
Drane, WE; Fenton, JJ; Harman, EM; Mastin, ST; Quesenberry, L | 1 |
Hoekstra, CJ; Hoekstra, OS; Postmus, PE; Smit, EF; Teengs, JP | 1 |
Buchmann, I; Buck, A; Elsner, K; Gfrörer, W; Guhlmann, CA; Kotzerke, J; Reske, SN; Schirrmeister, H | 1 |
Biersack, HJ; Briele, B; Grünwald, F; Ruhlmann, J; Willkomm, P | 1 |
Shreve, PD | 1 |
Al-Amro, A; Bakheet, SM; Larsson, SG; Mahassin, Z; Powe, J; Saleem, M | 1 |
Akiyama, Y; Hara, T; Inagaki, K; Kudo, K; Morita, T; Soma, T; Suzuki, T; Takeda, Y; Tnabe, M; Yano, M | 1 |
Alavi, A; Pourdehnad, M; Rossman, MD; Yamamoto, AJ; Zhuang, H | 1 |
Brink, I; Hasse, J; Imdahl, A; Jenkner, S; Moser, E; Nitzsche, E; Stoelben, E | 1 |
Fuentes, MA; Griffiths, MR; Miles, KA | 1 |
Chen, T; Hayashi, K; Ichiya, Y; Kaneko, K; Koga, H; Kuwabara, Y; Masuda, K; Nakagawa, M; Sasaki, M; Yoshida, T | 1 |
Abiko, K; Aikawa, T; Hatazawa, J; Ido, T; Ito, M; Ojima, F; Sasaki, H; Takahashi, T; Takishima, T; Yanai, M | 1 |
16 review(s) available for fluorodeoxyglucose f18 and Lung Diseases
Article | Year |
---|---|
Evolving Role of Novel Quantitative PET Techniques to Detect Radiation-Induced Complications.
Topics: Cardiovascular Diseases; Cardiovascular System; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiation Dosage; Radiation Injuries; Radiopharmaceuticals | 2020 |
Molecular Imaging of Pulmonary Inflammation and Infection.
Topics: Citrates; Fluorodeoxyglucose F18; Gallium; Humans; Lung; Lung Diseases; Magnetic Resonance Imaging; Molecular Imaging; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2020 |
Cardiothoracic manifestations of Erdheim-Chester disease.
Topics: Contrast Media; Erdheim-Chester Disease; Fluorodeoxyglucose F18; Heart Diseases; Humans; Lung Diseases; Magnetic Resonance Imaging; Mediastinal Diseases; Multimodal Imaging; Pleural Diseases; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2019 |
Thorax: normal and benign pathologic patterns in FDG-PET/CT imaging.
Topics: Amyloidosis; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Heart Diseases; Humans; Infections; Lung Diseases; Mediastinal Diseases; Multimodal Imaging; Myocardium; Pleural Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Spinal Diseases; Thoracic Diseases; Thoracic Injuries; Thoracic Vertebrae; Thorax; Tissue Distribution; Tomography, X-Ray Computed | 2014 |
Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis.
Topics: Diagnosis, Differential; Endemic Diseases; Fluorodeoxyglucose F18; Humans; Infections; Lung Diseases; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2014 |
Dual-time-point Imaging and Delayed-time-point Fluorodeoxyglucose-PET/Computed Tomography Imaging in Various Clinical Settings.
Topics: Atherosclerosis; Breast Neoplasms; Crohn Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2016 |
ACR Appropriateness Criteria Review ACR Appropriateness Criteria® Occupational Lung Diseases.
Topics: Anthracosis; Asbestosis; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Occupational Diseases; Positron-Emission Tomography; Radiology; Radiopharmaceuticals; Silicosis; Societies, Medical; Tomography, X-Ray Computed; United States | 2016 |
PET/CT in nononcological lung diseases: current applications and future perspectives.
Topics: Diffusion of Innovation; Fluorodeoxyglucose F18; Forecasting; Humans; Lung; Lung Diseases; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Severity of Illness Index | 2016 |
Quantification of Lung PET Images: Challenges and Opportunities.
Topics: Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung; Lung Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Respiratory Function Tests; Sensitivity and Specificity | 2017 |
[PET-CT in thoracic disease].
Topics: Bronchial Diseases; Contraindications; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Diseases; Mediastinal Diseases; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Diseases; Positron-Emission Tomography; Pregnancy; Radiopharmaceuticals; Thoracic Diseases; Tomography, X-Ray Computed | 2010 |
Nuclear medicine and molecular imaging of the pediatric chest: current practical imaging assessment.
Topics: Adolescent; Child; Child, Preschool; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Heart; Heart Diseases; Humans; Infant; Iodine Radioisotopes; Lung; Lung Diseases; Lung Neoplasms; Lymphoma; Molecular Imaging; Musculoskeletal Diseases; Myocardial Perfusion Imaging; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Compounds; Thymus Neoplasms; Tomography, X-Ray Computed; Xenon Radioisotopes | 2011 |
Novel molecular imaging in lung and pleural diseases.
Topics: Female; Fluorodeoxyglucose F18; Gamma Rays; Humans; Lung Diseases; Lung Neoplasms; Male; Molecular Imaging; Pleural Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review.
Topics: Aged; Aged, 80 and over; Amyloid; Amyloidosis; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
PET scanning in lung cancer: current status and future directions.
Topics: Combined Modality Therapy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Patient Selection; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Molecular imaging for pediatric lung diseases.
Topics: Diagnostic Imaging; Fluorodeoxyglucose F18; Gene Expression; Genes, Reporter; Humans; Inflammation; Lung Diseases; Radiopharmaceuticals | 2004 |
False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities.
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
6 trial(s) available for fluorodeoxyglucose f18 and Lung Diseases
Article | Year |
---|---|
Topics: Activities of Daily Living; Acute Disease; Adalimumab; Adaptation, Physiological; Adenosine Triphosphate; Adipose Tissue; Administration, Intravaginal; Adolescent; Adsorption; Adult; Adverse Childhood Experiences; Age Distribution; Age Factors; Aged; Aged, 80 and over; Air Pollution, Indoor; Aldehyde Oxidase; Alginates; Alloys; alpha-Globins; Aluminum Hydroxide; Alveolar Bone Loss; Anaerobiosis; Anesthesia, General; Anesthetics; Animals; Anovulation; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Bacillus cereus; Bacterial Typing Techniques; Bacteroidetes; Base Composition; Biocompatible Materials; Biofilms; Biological Availability; Biological Transport; Biosensing Techniques; Bipolar Disorder; Blood Glucose; Body Mass Index; Bone Regeneration; Boranes; Brachial Artery; Butyric Acid; Candida albicans; Carbon; Carcinoembryonic Antigen; Cell Differentiation; Cell Line, Tumor; Cell Respiration; Cell Survival; Cells, Cultured; Cerebrovascular Circulation; Charcoal; Child; Child Health; China; Chloride Channels; Chlorides; CHO Cells; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromium; Chronic Disease; Chronic Periodontitis; Circular Dichroism; Cities; Cohort Studies; Comamonadaceae; Comorbidity; Coronary Artery Disease; Corrosion; Cricetinae; Cricetulus; Cross Infection; Cross-Sectional Studies; Crowding; Culture Media; Cytokines; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diarylheptanoids; Diclofenac; Disability Evaluation; Diterpene Alkaloids; DNA; DNA Mutational Analysis; DNA, Bacterial; Drug Liberation; Drug Resistance, Multiple, Bacterial; Electrochemical Techniques; Electrodes; Electrolytes; Endothelium, Vascular; Enterococcus faecalis; Epithelial Cell Adhesion Molecule; Epithelial Cells; Erbium; Erythropoietin; Ethanol; Ethylenediamines; Fast Foods; Fatty Acids; Female; Fermentation; Ferric Compounds; Fibroblasts; Flavobacteriaceae; Fluorides; Fluorodeoxyglucose F18; Food Microbiology; Formaldehyde; Furaldehyde; Gamma Cameras; Gene Expression; Geologic Sediments; Glucose Tolerance Test; Glycated Hemoglobin; Glycolipids; Glycosylation; Gracilaria; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Guanine; Health Surveys; HeLa Cells; Hemoglobins, Abnormal; Hexosamines; High Fructose Corn Syrup; High-Intensity Interval Training; Hip Fractures; Hippocampus; HLA-B27 Antigen; Hospitalization; Housing; Humans; Hydrogen-Ion Concentration; Hydrolysis; Hydroxides; Hypercapnia; Hypertension; Hypocreales; Hypromellose Derivatives; Image Processing, Computer-Assisted; Incidence; Indole Alkaloids; Indonesia; Inflammation Mediators; Infrared Rays; Insulin Resistance; Intercalating Agents; Ion Transport; Ionophores; Japan; Kinetics; Kluyveromyces; Letrozole; Linear Models; Lipopolysaccharides; Liposomes; Liver; Lung Diseases; Magnesium Hydroxide; Magnetic Resonance Spectroscopy; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Middle Aged; Mitochondria; Mitochondria, Muscle; Molecular Docking Simulation; Molecular Structure; Muscle, Skeletal; Mutant Proteins; Mutation; Mutation, Missense; Nanocomposites; Nanoparticles; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Nucleic Acid Hybridization; Obesity; Occupational Exposure; Oceans and Seas; Odds Ratio; Organometallic Compounds; Osteogenesis; Ovulation Induction; Oxidation-Reduction; Particle Size; Periodontal Ligament; Permeability; Phaseolus; Phenotype; Philippines; Phosphatidylethanolamines; Phospholipids; Photochemical Processes; Phylogeny; Pichia; Pigmentation; Plant Extracts; Polycystic Ovary Syndrome; Polysaccharides; Postprandial Period; Pregnancy; Pregnancy Rate; Prevalence; Product Surveillance, Postmarketing; Progesterone; Progestins; Protein Engineering; Pseudomonas aeruginosa; Psoriasis; Public Facilities; Rats; Rats, Wistar; Receptors, Thyrotropin; Recombinant Proteins; Reproducibility of Results; Republic of Korea; Retrospective Studies; Rhodobacteraceae; Risk; Risk Assessment; Risk Factors; RNA, Ribosomal, 16S; ROC Curve; Saccharomyces cerevisiae; Salinity; Saliva; Seawater; Seaweed; Sensitivity and Specificity; Sequence Analysis, DNA; Sex Factors; Silver Compounds; Smokers; Social Class; Socioeconomic Factors; Soil Microbiology; Solubility; Soy Foods; Spectrometry, Mass, Electrospray Ionization; Spondylitis, Ankylosing; Staphylococcus aureus; Static Electricity; Steroids; Strontium; Sucrose; Surface Properties; Survival Rate; Sweden; Swine; Synapses; Synchrotrons; Tandem Mass Spectrometry; Tannins; Tea; Temperature; Terpenes; Thalidomide; Thermodynamics; Thiadiazoles; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tissue Distribution; Titanium; Toilet Facilities; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ubiquinone; Urinary Tract Infections; Vaginal Creams, Foams, and Jellies; Venezuela; Vitamin K 2; Waist Circumference; Waste Disposal, Fluid; Wastewater; Water Microbiology; Water Pollutants, Chemical; Whole Body Imaging; X-Ray Diffraction; Young Adult; Ytterbium; Yttrium; Yttrium Radioisotopes; Zinc Compounds | 2018 |
The influence of interpreters' professional background and experience on the interpretation of multimodality imaging of pulmonary lesions using 18F-3'-deoxy-fluorothymidine and 18F-fluorodeoxyglucose PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Clinical Competence; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
18F-FDG PET/CT lung 'focalities' without coregistered CT findings: an interpretative clinical dilemma.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung; Lung Diseases; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Can multimodality imaging using 18F-FDG/18F-FLT PET/CT benefit the diagnosis and management of patients with pulmonary lesions?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2011 |
Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Topics: Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Endometrial Neoplasms; Esophagoscopy; Female; Fluorodeoxyglucose F18; Granuloma; Histiocytosis; Histoplasmosis; Humans; Kidney Neoplasms; Lung Diseases; Lung Neoplasms; Lymphatic Diseases; Lymphatic Metastasis; Lymphoma; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Silicosis; Tomography, X-Ray Computed; Ultrasonography, Interventional; Urinary Bladder Neoplasms | 2005 |
118 other study(ies) available for fluorodeoxyglucose f18 and Lung Diseases
Article | Year |
---|---|
18F-FDG PET/CT imaging in the diagnosis of drug-induced lung disease and pulmonary infection in lymphoma.
Topics: Adult; Aged; Drug Interactions; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Pulmonary actinomycosis mimicking lung cancer on
Topics: Actinomycosis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2022 |
Slowly Expanding 18 F-FDG PET-Positive Irregular Opacities in the Lung Due to Diffuse Lymphoid Hyperplasia Preceding Rheumatoid Arthritis.
Topics: Arthritis, Rheumatoid; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lung; Lung Diseases; Lymphoproliferative Disorders; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2023 |
All that glitters is not gold.
Topics: Adipose Tissue; Adult; Fluorodeoxyglucose F18; Hamartoma; Humans; Lung Diseases; Male; Positron Emission Tomography Computed Tomography; Radiography, Thoracic; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2019 |
Spectrum of 18F-FDG Uptake in Bilateral Lung Parenchymal Diseases on PET/CT.
Topics: Adult; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2020 |
Lung Involvement in Destombes-Rosai-Dorfman Disease: Clinical and Radiological Features and Response to the MEK Inhibitor Cobimetinib.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Azetidines; Bronchoalveolar Lavage Fluid; Cough; Dyspnea; Female; Fluorodeoxyglucose F18; France; Histiocytosis, Sinus; Humans; Immunosuppressive Agents; Lung; Lung Diseases; Lymphocytosis; Male; Middle Aged; Piperidines; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Radiopharmaceuticals; Registries; Retrospective Studies; Young Adult | 2020 |
Features of IgG4-related lung disease on 18F-FDG PET/computed tomography imaging.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunoglobulin G; Lung Diseases; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2020 |
Consensus Recommendations on the Use of
Topics: Consensus; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Injections; Lung Diseases; Patient Positioning; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Respiration | 2020 |
Impact of Glucose Uptake of Noncancerous Lung Area in Respiratory Events for Lung Cancer Patients.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Young Adult | 2021 |
The value of 4D fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of lung lesions.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Diseases; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2020 |
FDG-Avid Pulmonary Nodules and Tracheobronchial Mural Inflammation in IgG4-Related Disease.
Topics: Biological Transport; Child; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G4-Related Disease; Inflammation; Lung Diseases; Positron Emission Tomography Computed Tomography | 2021 |
Desmoplastic Small Round Cell Tumor of the Kidney With Mainly Pulmonary Symptoms by
Topics: Adult; Desmoplastic Small Round Cell Tumor; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Diseases; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Potential Clinical Utility of FDG-PET in Non-malignant Pulmonary Disorders: A Pilot Study.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Male; Middle Aged; Monitoring, Physiologic; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome | 2016 |
The role of F-18 FDG PET/CT in differentiating benign from malignant pulmonary masses and accompanying lymph nodes.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2018 |
The value of 18F-FDG PET/CT in the diagnosis of different size of solitary pulmonary nodules.
Topics: Diagnosis, Differential; Dimensional Measurement Accuracy; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tumor Burden | 2019 |
Nivolumab-Associated Pulmonary and Bone Sarcoidosis in a Patient With Melanoma of Unknown Primary.
Topics: Bone Diseases; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lymphadenopathy; Male; Melanoma; Middle Aged; Neoplasms, Unknown Primary; Nivolumab; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2019 |
An implementation of time-efficient respiratory-gated PET acquisition by repeated breath-holds.
Topics: Artifacts; Fluorodeoxyglucose F18; Humans; Liver Diseases; Lung Diseases; Multimodal Imaging; Patient Positioning; Positron-Emission Tomography; Radiopharmaceuticals; Respiration; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
IgG4-related lung disease showing high standardized uptake values on FDG-PET: report of two cases.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Lung Diseases; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2013 |
[Sensitivity of PET with 18F-fluorodesoxyglucose in the diagnosis of neuroendocrine tumors of the lungs].
Topics: Adult; Aged; Carcinoid Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Small Cell Lung Carcinoma | 2013 |
Pulmonary alveolar microlithiasis: imaging characteristics of planar and SPECT/CT bone scan versus 18F-FDG and 18F-sodium fluoride PET/CT scanning.
Topics: Calcinosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genetic Diseases, Inborn; Humans; Lung Diseases; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Rare Diseases; Sensitivity and Specificity; Sodium Fluoride; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2013 |
Pulmonary amyloidosis in a patient with Langerhans cell histiocytosis: diagnostic dilemma on 18F-FDG PET/CT.
Topics: Amyloidosis; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Humans; Lung Diseases; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Pulmonary brucellosis on FDG PET/CT.
Topics: Aged; Brucellosis; Fluorodeoxyglucose F18; Humans; Lung Diseases; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
18F-FDG PET scanning in pulmonary amyloidosis.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lung Neoplasms; Lymphoma; Male; Middle Aged; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Function Tests; Risk Factors; Tomography, X-Ray Computed | 2014 |
Positive positron emission tomography/computed tomography scan and multiple pulmonary nodules: an unusual diagnosis.
Topics: Aged, 80 and over; Amyloidosis; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
Topics: Adolescent; Adult; Aged; Algorithms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Diseases; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Random Allocation; Reproducibility of Results; Respiration; Tomography, X-Ray Computed; Young Adult | 2014 |
Potential of 18F-FDG-PET and PET/CT in nonmalignant pulmonary disorders: much more than currently perceived? Making the case from experience gained in the Indian scenario.
Topics: Fluorodeoxyglucose F18; Humans; India; Lung Diseases; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Functional imaging with diffusion-weighted MRI for lung biopsy planning: initial experience.
Topics: Adult; Aged; Biopsy; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lung Diseases; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
4D numerical observer for lesion detection in respiratory-gated PET.
Topics: Algorithms; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Diseases; Models, Biological; Monte Carlo Method; Motion; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Respiratory-Gated Imaging Techniques; Signal-To-Noise Ratio | 2014 |
The applications of corrected standardized uptake values in the diagnosis of peripheral lung lesions.
Topics: Fluorodeoxyglucose F18; Humans; Lung Diseases; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Findings on early treatment response assessment with 18F-FDG PET/CT as a pointer toward a 'second-look' at the diagnosis: an ancillary observation but with potential implications for patient management in a multidisciplinary setting.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lung Diseases; Male; Multimodal Imaging; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Respiratory-gated imaging in metabolic evaluation of small solitary pulmonary nodules: 18F-FDG PET/CT and correlation with histology.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
A Retrospective Study of Pulmonary Actinomycosis in a Single Institution in China.
Topics: Actinomycosis; Adult; Aged; China; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Male; Middle Aged; Positron-Emission Tomography; Radiography; Retrospective Studies; Treatment Outcome | 2015 |
Solitary pulmonary amyloidoma mimicking lung cancer on 18F-FDG PET-CT scan in systemic lupus erythematosus patient.
Topics: Amyloidosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Lupus Erythematosus, Systemic; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2015 |
Effect of Time-of-Flight Information on PET/MR Reconstruction Artifacts: Comparison of Free-breathing versus Breath-hold MR-based Attenuation Correction.
Topics: Adult; Aged; Artifacts; Breath Holding; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Respiration; Signal-To-Noise Ratio | 2017 |
Correlation of Glut-1 and Glut-3 expression with F-18 FDG uptake in pulmonary inflammatory lesions.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Immunohistochemistry; Inflammation; Lung Diseases; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5.
Topics: Adult; Aged; Algorithms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Solitary Pulmonary Nodule; Statistics, Nonparametric; Tuberculosis, Pulmonary | 2008 |
Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
[18F]FDG hot spot in lung disappearing on repeat study.
Topics: Fluorodeoxyglucose F18; Humans; Infant, Newborn; Lung; Lung Diseases; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission, Spontaneous | 2008 |
Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program.
Topics: Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
Imaging of lung hamartomas by multidetector computed tomography and positron emission tomography.
Topics: Adult; Aged; Cohort Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hamartoma; Humans; Lung Diseases; Male; Middle Aged; Pneumonectomy; Positron-Emission Tomography; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections; Positron-Emission Tomography; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Treatment Outcome; Tuberculoma | 2009 |
Characterization of pulmonary lesions with low F-18 FDG uptake using double phase F-18 FDG PET/CT: comparison of visual and quantitative analyses.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2009 |
Lung sequestration and Pott disease masquerading as primary lung cancer with bone metastases on FDG PET/CT.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Spondylitis; Tomography, X-Ray Computed; Tuberculosis, Spinal | 2009 |
[18F]-fluorodeoxyglucose positron emission tomography combined with computed tomography detection of asymptomatic late pulmonary toxicity in patients with non-Hodgkin lymphoma treated with rituximab-containing chemotherapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Retrospective Studies; Rituximab; Tomography, X-Ray Computed | 2009 |
Incidental findings on follow-up fluorodeoxyglucose positron emission tomography studies in lymphoma patients: beware the outlier.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Lung Diseases; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Rituximab; Tomography, X-Ray Computed | 2009 |
Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG PET/CT: prevalence and disease pattern.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Diseases; Male; Mediastinal Diseases; Middle Aged; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed | 2009 |
Nodular lymphoid hyperplasia: rare case of lymphoproliferative disease in the lung.
Topics: Adolescent; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lymphoproliferative Disorders; Pneumonectomy; Positron-Emission Tomography; Pseudolymphoma; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity.
Topics: Diagnosis, Differential; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2010 |
Imaging the molecular signatures of apoptosis and injury with radiolabeled annexin V.
Topics: Annexin A5; Apoptosis; Autophagy; Fluorodeoxyglucose F18; Humans; Lung Diseases; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2009 |
18F-fluorodeoxyglucose positron emission tomographic imaging of pulmonary functions, pathology, and drug delivery.
Topics: Administration, Inhalation; Bronchoconstriction; Drug Delivery Systems; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Diseases; Particle Size; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Respiratory Therapy | 2009 |
[A case of pulmonary actinomycosis in which differentiation of primary and metastatic lung cancers was difficult].
Topics: Actinomycosis; Aged; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Multifocal nodular lymphoid hyperplasia of the lung differently identified by 18F-fluorodeoxyglucose positron emission tomography (FDG-PET).
Topics: Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Multiple Pulmonary Nodules; Positron-Emission Tomography; Pseudolymphoma; Radiopharmaceuticals; Thoracoscopy; Tomography, X-Ray Computed | 2009 |
[PET-CT in evaluation of pulmonary nodule--case report].
Topics: Adenocarcinoma, Clear Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Diseases; Lung Neoplasms; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2009 |
Pulmonary amyloidosis mimicking multiple metastatic lesions on F-18 FDG PET/CT.
Topics: Amyloidosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Nodular lymphoid hyperplasia of the lung: the role of positron emission tomography in diagnosis.
Topics: Fluorodeoxyglucose F18; Humans; Lung Diseases; Male; Middle Aged; Multiple Pulmonary Nodules; Pseudolymphoma; Radionuclide Imaging; Radiopharmaceuticals | 2009 |
Commentary on "Positron Emission Tomography in the Lung" 25 years after publication in the inaugural issue of the Journal of Thoracic Imaging.
Topics: Contrast Media; Fluorodeoxyglucose F18; History, 20th Century; Humans; Lung; Lung Diseases; Periodicals as Topic; Positron-Emission Tomography; Radiographic Image Enhancement | 2010 |
Findings of pulmonary amyloidosis on dual phase FDG PET/CT imaging.
Topics: Amyloidosis; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Inflammatory pseudotumor of the lung with high FDG uptake.
Topics: Female; Fluorodeoxyglucose F18; Granuloma, Plasma Cell; Humans; Lung Diseases; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2010 |
18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm.
Topics: Adult; Aged; Bronchoscopy; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2010 |
Clinically unrecognized pulmonary aspiration during gastrointestinal endoscopy with sedation: a potential pitfall interfering the performance of 18F-FDG PET for cancer screening.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia; Artifacts; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Incidental Findings; Lung Diseases; Male; Mass Screening; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2011 |
Preferred method for the diagnostic evaluation of ground-glass opacities.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
Intraocular sarcoidosis: association of clinical characteristics of uveitis with findings from 18F-labelled fluorodeoxyglucose positron emission tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Diseases; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed; Uveitis; Whole Body Imaging; Young Adult | 2012 |
Diffusion-weighted magnetic resonance for pulmonary nodules: 1.5 vs. 3 Tesla.
Topics: Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Japan; Lung Diseases; Lung Neoplasms; Multiple Pulmonary Nodules; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Radiological experience needed when assessing PET/CT imaging.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Endemic Diseases; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Likelihood Functions; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tennessee | 2011 |
[18-FDG PET-scan of intrathoracic gossypiboma during the monitoring of lung cancer].
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Humans; Lung Diseases; Lung Neoplasms; Male; Monitoring, Physiologic; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Reoperation; Risk Factors; Smoking; Surgical Sponges; Treatment Outcome | 2011 |
Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis.
Topics: Adult; Aged; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Diseases; Male; Middle Aged; Multimodal Imaging; Neopterin; Netherlands; Peptidyl-Dipeptidase A; Positron-Emission Tomography; Predictive Value of Tests; Quality of Life; Radiopharmaceuticals; Receptors, Interleukin-2; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2011 |
Fluorine-18-fluorodeoxyglucose PET/CT rare finding of a unique multiorgan involvement of Wegener's granulomatosis.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Granulomatosis with Polyangiitis; Humans; Lung Diseases; Male; Maxillary Sinus; Parotid Gland; Positron-Emission Tomography; Prostatic Diseases; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal, Humanized; Biopsy, Needle; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Injections, Subcutaneous; Lung Diseases; Male; Middle Aged; Positron-Emission Tomography; Prednisolone; Prospective Studies; Respiratory Function Tests; Sarcoidosis; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2012 |
[IL-10 suppresses inflammatory granuloma uptake of 18F-FDG in rats].
Topics: Animals; Female; Fluorodeoxyglucose F18; Freund's Adjuvant; Granuloma; Interleukin-10; Lung Diseases; Male; Radiopharmaceuticals; Rats; Serum Albumin, Bovine | 2012 |
A case of pulmonary cholesterol granuloma: an (18)F-fluorodeoxyglucose positron emission tomography image.
Topics: Aged; Cholesterol; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Diseases; Positron-Emission Tomography | 2012 |
Imaging pulmonary gene expression with positron emission tomography.
Topics: Analysis of Variance; Animals; Enzyme-Linked Immunosorbent Assay; Fluorodeoxyglucose F18; Gene Expression; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Guanine; Herpesvirus 1, Human; Least-Squares Analysis; Lung; Lung Diseases; Models, Animal; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Thymidine Kinase; Time Factors; Tomography, Emission-Computed; Transgenes; Treatment Outcome | 2003 |
Pulmonary clostridium perfringens infection detected by FDG positron emission tomography.
Topics: Aged; Aged, 80 and over; Clostridium Infections; Clostridium perfringens; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Uptake of fluorine-18-fluorodeoxyglucose in pulmonary Mycobacterium avium complex infection.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Male; Mycobacterium avium-intracellulare Infection; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
CT with histopathologic correlation of FDG uptake in a patient with pulmonary granuloma and pleural plaque caused by remote talc pleurodesis.
Topics: Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Humans; Lung Diseases; Male; Middle Aged; Pleural Diseases; Pleurodesis; Radiopharmaceuticals; Talc; Tomography, X-Ray Computed | 2004 |
[Positron emission tomography using 18-FDG-PET in radiologically indeterminate pulmonary lesions].
Topics: Adult; Aged; Diagnosis, Differential; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2004 |
False-positive FDG positron emission tomography in pulmonary amyloidosis.
Topics: Aged; Aged, 80 and over; Amyloidosis; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2004 |
Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy.
Topics: Adult; Brain Diseases; Citrates; False Negative Reactions; Fluorodeoxyglucose F18; Gallium; Humans; Lung Diseases; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2005 |
False positive accumulation in 18F fluorodeoxyglucose positron emission tomography scan due to sarcoid reaction following induction chemotherapy for lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2005 |
Pulmonary amyloidosis: detection with PET-CT.
Topics: Amyloidosis; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Fluorodeoxyglucose (FDG) uptake in pulmonary rheumatoid nodules.
Topics: Arthritis, Rheumatoid; Biopsy, Needle; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lung Diseases; Middle Aged; Positron-Emission Tomography; Radiography, Thoracic; Risk Assessment; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2005 |
PET imaging of cerebral and pulmonary Nocardia infection.
Topics: Aged; Brain Abscess; Fluorodeoxyglucose F18; Humans; Lung Diseases; Male; Nocardia Infections; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Focal parenchymal lung lesions showing a potential of false-positive and false-negative interpretations on integrated PET/CT.
Topics: Adult; Aged; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Male; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Two cases of pulmonary paragonimiasis on FDG-PET CT imaging.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Paragonimiasis; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Frozen Sections; Humans; Lung Diseases; Lung Diseases, Fungal; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2006 |
Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung; Lung Diseases; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed | 2006 |
Computed tomography (CT) and positron emission tomography with [18F]fluoro-2-deoxy-D-glucose (FDG-PET) images of pulmonary cryptococcosis mimicking lung cancer.
Topics: Adult; Aged; Cryptococcosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Pulmonary hyalinizing granuloma and retroperitoneal fibrosis in an adolescent.
Topics: Adolescent; Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucocorticoids; Granuloma; Humans; Hyalin; Lung Diseases; Magnetic Resonance Imaging; Male; Methylprednisolone; Prednisone; Radiopharmaceuticals; Retroperitoneal Fibrosis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Round pneumonia mimicking pulmonary malignancy on F-18 FDG PET/CT.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Pneumonia; Positron-Emission Tomography; Tomography, X-Ray Computed | 2007 |
Accuracy of PET/CT in characterization of solitary pulmonary lesions.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2007 |
F-18 FDG uptake due to acinetobacter infection causing misinterpretation of treatment response in a lymphoma patient.
Topics: Acinetobacter Infections; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lymphoma, B-Cell; Middle Aged; Prednisone; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine | 2007 |
[FDG-PET findings of nodular pulmonary amyloidosis with a long-term observation].
Topics: Amyloidosis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Diseases; Middle Aged; Positron-Emission Tomography | 2007 |
PET scintigraphy of etoposide-induced pulmonary toxicity.
Topics: Administration, Oral; Aged; Antineoplastic Agents, Phytogenic; Etoposide; Fluorodeoxyglucose F18; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases; Male; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases | 2007 |
Efficacy of PET/CT in the characterization of solid or partly solid solitary pulmonary nodules.
Topics: Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
[Benign and malignant solitary pulmonary nodules--PET/CT for differential diagnosis].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2008 |
[Evaluation of pulmonary lesions with positron emission tomography].
Topics: Blood Glucose; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Prospective Studies; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1994 |
Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.
Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Tomography, Emission-Computed | 1993 |
Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Granuloma; Humans; Lung Diseases; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Neurilemmoma; Pneumonia; Predictive Value of Tests; Radiography; Radionuclide Imaging; Sensitivity and Specificity; Tuberculosis, Pulmonary | 1996 |
Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings.
Topics: Carcinoma in Situ; Carcinoma, Non-Small-Cell Lung; Cicatrix; Deoxyglucose; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Lung Diseases; Lung Neoplasms; Neoplasm, Residual; Prospective Studies; Remission Induction; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 1996 |
Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cost-Benefit Analysis; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Pulmonary abnormalities and PET data analysis: a retrospective study.
Topics: Adult; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Observer Variation; Retrospective Studies; ROC Curve; Tomography, Emission-Computed | 1997 |
Fluorine-18-fluorodeoxyglucose uptake in rheumatoid arthritis-associated lung disease in a patient with thyroid cancer.
Topics: Arthritis, Rheumatoid; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Joints; Lung; Lung Diseases; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions.
Topics: Adenocarcinoma; Adult; Aged; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Granuloma; Humans; Lung Diseases; Lung Neoplasms; Mediastinal Diseases; Mediastinal Neoplasms; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
False-positive 2-[F-18]-fluoro-2-deoxy-D-glucose positron emission tomography studies for evaluation of focal pulmonary abnormalities.
Topics: Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Diseases; Tomography, Emission-Computed | 1998 |
FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET, and dedicated PET.
Topics: Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lung; Lung Diseases; Mediastinum; Phantoms, Imaging; Radiopharmaceuticals; Signal Processing, Computer-Assisted; Thorax; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
FDG SPECT in patients with lung masses.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1999 |
Thoracic actinomycosis imaging with fluorine-18 fluorodeoxyglucose positron emission tomography.
Topics: Actinomycosis; Carcinoma, Bronchogenic; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Tomography, Emission-Computed | 1999 |
[F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes].
Topics: Adult; Aged; Carcinoma, Bronchogenic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Pleural Effusion; Pleural Effusion, Malignant; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
[Imaging of secondary pulmonary changes in central bronchial carcinomas by F-18-FDG PET].
Topics: Aged; Carcinoma, Bronchogenic; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Pseudolymphoma of the lung: Benign pulmonary nodule with elevated fluorodeoxyglucose uptake.
Topics: Aged; Carcinoma, Bronchogenic; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Pseudolymphoma; Radionuclide Imaging; Radiopharmaceuticals | 2000 |
F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection.
Topics: Adult; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Respiratory Tract Infections; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
[Diagnostic efficacy of 18F-fluorodeoxy glucose-positron emission tomography in multiple solitary pulmonary nodules].
Topics: Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Granuloma, Lethal Midline; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Intense F-18 fluorodeoxyglucose uptake caused by mycobacterium avium intracellulare infection.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Male; Mycobacterium avium-intracellulare Infection; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Standardized perfusion value: universal CT contrast enhancement scale that correlates with FDG PET in lung nodules.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Perfusion; Radiographic Image Enhancement; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Comparison of MET-PET and FDG-PET for differentiation between benign lesions and malignant tumors of the lung.
Topics: Adult; Aged; Diagnosis, Differential; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Methionine; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2001 |
Preparation of a fine powder of 2-deoxy-2-[18F]fluoro-D-glucose suitable for inhalation to diagnose lung diseases by means of PET.
Topics: Administration, Inhalation; Animals; Deoxy Sugars; Deoxyglucose; Dogs; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Diseases; Powders; Tomography, Emission-Computed | 1989 |